Abivax (ABVX) Cash from Discontinued Operations (2025 - 2026)
Abivax (ABVX) recorded quarterly Cash from Discontinued Operations of 59144899.5 in Q1 2026, down 68.96% quarter-over-quarter from 35004610.38 in Q1 2025, and down 68.96% on a YoY basis from 190563599.23 in Q1 2025.
Abivax (ABVX) Cash from Discontinued Operations (2025 - 2026) Analysis & Trends
Abivax's Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 59144899.5 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -59.14 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.14 Mn |
| Mar 31, 2026 | -59.14 Mn |
| Mar 31, 2025 | -35.00 Mn |
| Mar 31, 2025 | -35.00 Mn |